Item
Vitamin C Ascorbic Acid (10036)
Ascorbic acid E300- 99.0-100.5%
Nutrient / Vitamin
Attributes
- Gluten-free
- Halal
- Ingredient declaration
- Kosher
- PHO-free
- Vegan
- Non-GMO
Locations
| Location name | Address |
|---|---|
| Jiangsu Jiangshan Pharmaceutical Co., Ltd. | No. 61, Jiangshan Road Jingjiang, JS 214500 CHN |
| Luwei Pharmaceutical Group Co., Ltd. | Shuangfeng Industrial Park Zibo City, SD 255190 CHN |
Documents
| Type | Location | File name | Effective | Expiration |
|---|---|---|---|---|
| GFSI Certificate | Jiangsu Jiangshan Pharmaceutical Co., Ltd. | 3rd Party Food Safety Certificate - 2025-03-14T100355.666.pdf | 9/6/2024 | 8/10/2026 |
| HACCP | Jiangsu Jiangshan Pharmaceutical Co., Ltd. | 3rd party-Haccp doc - Prinova.pdf | 7/20/2022 | 7/19/2025 |
| HACCP | Luwei Pharmaceutical Group Co., Ltd. | 3rd party-Haccp doc - Prinova.pdf | 6/20/2023 | 6/19/2026 |
| Food Defense Plan Statement | Jiangsu Jiangshan Pharmaceutical Co., Ltd. | 3rd party-Haccp doc - Prinova.pdf | 3/14/2025 | 3/14/2027 |
| HACCP Plan (Facility) | Jiangsu Jiangshan Pharmaceutical Co., Ltd. | 3rd party-Haccp doc - Prinova.pdf | 3/14/2025 | 3/14/2027 |
| Gluten | Jiangsu Jiangshan Pharmaceutical Co., Ltd. | Allergen - 2025-02-05T125041.807.pdf | 6/14/2024 | 6/14/2026 |
| Allergens | Luwei Pharmaceutical Group Co., Ltd. | Allergens.pdf | 7/15/2024 | 7/15/2026 |
| Allergens | Jiangsu Jiangshan Pharmaceutical Co., Ltd. | Allergens.pdf | 4/15/2025 | 4/15/2027 |
| CoA Sample | Luwei Pharmaceutical Group Co., Ltd. | Approved COA Template - 2025-01-07T131356.174.pdf | 4/6/2023 | 4/5/2025 |
| WADA/NSF/NFL Statement | Jiangsu Jiangshan Pharmaceutical Co., Ltd. | Banned Substance - 2025-01-07T162205.959.pdf | 6/15/2024 | 6/15/2026 |
| Country of Origin | Jiangsu Jiangshan Pharmaceutical Co., Ltd. | Country of Origin.pdf | 12/2/2022 | 12/1/2025 |
| Country of Origin | Luwei Pharmaceutical Group Co., Ltd. | Country of Origin.pdf | 6/12/2024 | 6/12/2027 |
| Dietary Supplement Questionnaire | Jiangsu Jiangshan Pharmaceutical Co., Ltd. | Dietary Supplement Questionnaire.pdf | 1/31/2022 | 1/31/2023 |
| HACCP Process Flow Diagram | Luwei Pharmaceutical Group Co., Ltd. | Flow Chart - 2024-07-02T154013.091.pdf | 4/6/2023 | 4/5/2025 |
| HACCP Process Flow Diagram | Jiangsu Jiangshan Pharmaceutical Co., Ltd. | Flow Chart.pdf | 4/11/2025 | 4/11/2027 |
| FSVP Assessment Form | Luwei Pharmaceutical Group Co., Ltd. | FSVP Assessment Form.pdf | 1/25/2021 | 1/25/2022 |
| GMO | Jiangsu Jiangshan Pharmaceutical Co., Ltd. | GMO - 2025-02-05T124916.839.pdf | 6/12/2024 | 6/12/2026 |
| Letter of Guarantee | Jiangsu Jiangshan Pharmaceutical Co., Ltd. | GUARANTEE Nutrivo.pdf | 3/14/2025 | 3/14/2027 |
| Halal | Luwei Pharmaceutical Group Co., Ltd. | Halal Certificate - 2024-07-02T151124.953.pdf | 6/19/2024 | 6/19/2026 |
| Item Questionnaire | Luwei Pharmaceutical Group Co., Ltd. | Item Questionnaire.pdf | 5/26/2022 | 5/25/2025 |
| Item Questionnaire | Jiangsu Jiangshan Pharmaceutical Co., Ltd. | Item Questionnaire.pdf | 4/4/2025 | 4/3/2028 |
| Pesticide | Jiangsu Jiangshan Pharmaceutical Co., Ltd. | Jiangsu Jiangshan (JSPC) - Ascorbic acid - Contaminants and Impurities.pdf | 4/14/2025 | 4/14/2027 |
| Irradiation Status Statement | Jiangsu Jiangshan Pharmaceutical Co., Ltd. | Jiangsu Jiangshan (JSPC) - Ascorbic acid - Organic Use Status.pdf | 4/14/2025 | 4/14/2027 |
| Sewage Statement | Jiangsu Jiangshan Pharmaceutical Co., Ltd. | Jiangsu Jiangshan (JSPC) - Ascorbic acid - Organic Use Status.pdf | 4/14/2025 | 4/14/2027 |
| California Prop. 65 | Jiangsu Jiangshan Pharmaceutical Co., Ltd. | Jiangsu Jiangshan (JSPC) - Ascorbic acid - Product Info Sheet.pdf | 4/14/2025 | 4/14/2027 |
| Heavy Metal | Jiangsu Jiangshan Pharmaceutical Co., Ltd. | Jiangsu Jiangshan (JSPC) - Ascorbic acid - Spec.pdf | 4/14/2025 | 4/14/2027 |
| CoA Sample | Jiangsu Jiangshan Pharmaceutical Co., Ltd. | JSPC - Ascorbic acid - COA.pdf | 4/11/2025 | 4/11/2027 |
| Kosher | Jiangsu Jiangshan Pharmaceutical Co., Ltd. | Kosher Certificate - 2025-01-16T154411.299.pdf | 1/16/2025 | 12/31/2025 |
| Kosher | Luwei Pharmaceutical Group Co., Ltd. | Kosher Certificate - 2025-03-26T095658.242.pdf | 3/13/2025 | 3/31/2026 |
| Label Sample | Jiangsu Jiangshan Pharmaceutical Co., Ltd. | Label - 2025-02-07T130648.124.pdf | 11/21/2025 | 11/21/2026 |
| Halal | Jiangsu Jiangshan Pharmaceutical Co., Ltd. | MUI HALAL_Product Attachment (JSPC).pdf | 3/21/2023 | 3/20/2027 |
| National Bioengineered Food Disclosure Standard (Simplified) | Jiangsu Jiangshan Pharmaceutical Co., Ltd. | National Bioengineered Food Disclosure Standard (Simplified).pdf | 2/4/2025 | 2/4/2028 |
| Nutrition | Jiangsu Jiangshan Pharmaceutical Co., Ltd. | Nutrition.pdf | 11/8/2019 | 11/7/2022 |
| Nutrition | Luwei Pharmaceutical Group Co., Ltd. | Nutrition.pdf | 7/2/2024 | 7/2/2027 |
| Natural | Jiangsu Jiangshan Pharmaceutical Co., Ltd. | Organic Compliance - 2025-04-02T135951.208.pdf | 4/2/2025 | 4/2/2026 |
| Lot Code | Luwei Pharmaceutical Group Co., Ltd. | Packaging Declaration - 2024-06-03T103731.519.pdf | 4/6/2023 | 4/5/2026 |
| Residual Statement | Jiangsu Jiangshan Pharmaceutical Co., Ltd. | Product Data Sheet - 2023-03-29T154945.098.pdf | 1/8/2023 | 1/8/2024 |
| Ingredient Statement | Jiangsu Jiangshan Pharmaceutical Co., Ltd. | Product Data Sheet - 2024-10-21T134957.366.pdf | 6/12/2024 | 6/12/2027 |
| Lot Code | Jiangsu Jiangshan Pharmaceutical Co., Ltd. | Product Data Sheet 74.pdf | 1/8/2021 | 1/8/2024 |
| BSE - TSE | Jiangsu Jiangshan Pharmaceutical Co., Ltd. | Product Data Sheet 74.pdf | 1/8/2021 | 1/8/2024 |
| EtO Statement | Jiangsu Jiangshan Pharmaceutical Co., Ltd. | Production Process (92).pdf | 6/19/2024 | 6/19/2026 |
| Ingredient Statement | Luwei Pharmaceutical Group Co., Ltd. | RE_ Luwei ascorbic acid - docs 1 (6).pdf | 6/11/2023 | 6/10/2024 |
| Vegan/Vegetarian Statement | Jiangsu Jiangshan Pharmaceutical Co., Ltd. | Regulatory Information Sheet - 2025-02-05T124645.621.pdf | 6/14/2024 | 6/14/2026 |
| Safety Data Sheet (SDS) | Luwei Pharmaceutical Group Co., Ltd. | SDS - 2024-06-12T155355.101.pdf | 1/1/2024 | 12/31/2026 |
| Safety Data Sheet (SDS) | Jiangsu Jiangshan Pharmaceutical Co., Ltd. | SDS CA.pdf | 10/23/2020 | 10/23/2023 |
| Suitability Requirements | Luwei Pharmaceutical Group Co., Ltd. | Suitability Requirements.pdf | 11/2/2022 | 11/1/2025 |
| Suitability Requirements | Jiangsu Jiangshan Pharmaceutical Co., Ltd. | Suitability Requirements.pdf | 8/1/2023 | 7/31/2026 |
| GRAS/NDI/ODI Statement | Jiangsu Jiangshan Pharmaceutical Co., Ltd. | US Regulatory Status - 2024-07-01T132436.330.pdf | 7/1/2024 | 7/1/2027 |
| Product Specification Sheet | Luwei Pharmaceutical Group Co., Ltd. | US SPECIFICATION - 2025-03-07T124743.408.pdf | 3/7/2025 | 3/6/2028 |
| Label Sample | Luwei Pharmaceutical Group Co., Ltd. | VIT C Regular 613 Shandong Luwei - Packaging Declaration CN Amended 2.pdf | 6/17/2020 | 6/17/2021 |
| Gluten | Luwei Pharmaceutical Group Co., Ltd. | VIT C Regular 613 Shandong Luwei - Regulatory Information CN 1.pdf | 6/18/2020 | 6/18/2021 |
